# Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)

> **NCT00289913** · PHASE4 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 1274 (actual)

## Conditions studied

- Hepatitis A Virus

## Interventions

- **BIOLOGICAL:** Comparator: VAQTA™
- **BIOLOGICAL:** Comparator: Infanrix™
- **BIOLOGICAL:** Comparator: PedvaxHIB™

## Key facts

- **NCT ID:** NCT00289913
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 1274 (ACTUAL)
- **Last updated:** 2017-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00289913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00289913, "Concomitant Use of Hepatitis A Vaccine, Inactivated With Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) and Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Given to Healthy Children 15 Months of Age (V251-068)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00289913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*